Related Experiment Video
Updated: Jul 10, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary hypertension: evaluation and management.
Gustavo A Heresi1, Raed A Dweik
1Department of Pulmonary, Allergy and Critical Care Medicine, Cleveland Clinic, 9500 Euclid Avenue/A90, Cleveland, OH, 44195, USA.
Pulmonary hypertension (PH) is a serious condition affecting pulmonary arteries, often leading to right heart failure. Early detection and specialized care are crucial for managing this rare disease, particularly idiopathic pulmonary arterial hypertension (IPAH).
Area of Science:
- Cardiology
- Pulmonology
- Internal Medicine
Background:
- Pulmonary hypertension (PH) is a hemodynamic condition defined by elevated pulmonary arterial pressure and resistance, potentially causing right ventricular failure and mortality.
- PH encompasses various etiologies, necessitating differentiation between pulmonary arterial hypertension (PAH) and pulmonary venous hypertension (PVH) linked to left heart disease.
- Idiopathic pulmonary arterial hypertension (IPAH), previously primary pulmonary hypertension (PPH), is a rare condition predominantly affecting women of childbearing age.
Purpose of the Study:
- To elucidate the diagnostic criteria and management strategies for pulmonary hypertension (PH).
- To emphasize the importance of distinguishing between different forms of PH, such as PAH and PVH.
- To highlight the specific characteristics and challenges associated with idiopathic pulmonary arterial hypertension (IPAH).
Main Methods:
- Noninvasive detection using Transthoracic Doppler echocardiography.
- Confirmatory diagnosis via right heart catheterization.
- Comprehensive workup including laboratory tests and imaging to exclude secondary causes.
Main Results:
- Nonspecific symptoms like dyspnea on exertion and fatigue are common in IPAH.
- Echocardiography serves as an effective screening tool, but right heart catheterization is essential for diagnosis.
- Recent advancements offer targeted treatments including prostanoids, endothelin receptor antagonists, and phosphodiesterase type-5 inhibitors.
Conclusions:
- Accurate diagnosis of PH requires a multi-faceted approach, combining noninvasive and invasive methods.
- Distinguishing IPAH from other forms of PH is critical for appropriate management.
- Patients with PH require specialized care at expert centers due to the complexity of treatment and disease management.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism III: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

